108 related articles for article (PubMed ID: 19840488)
1. [Notch signaling pathway and multiple myeloma].
Gan ZH; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1380-3. PubMed ID: 19840488
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy.
Nefedova Y; Sullivan DM; Bolick SC; Dalton WS; Gabrilovich DI
Blood; 2008 Feb; 111(4):2220-9. PubMed ID: 18039953
[TBL] [Abstract][Full Text] [Related]
3. Notch increased vitronection adhesion protects myeloma cells from drug induced apoptosis.
Ding Y; Shen Y
Biochem Biophys Res Commun; 2015 Nov; 467(4):717-22. PubMed ID: 26494298
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of gamma-secretase affects proliferation of leukemia and hepatoma cell lines through Notch signaling.
Suwanjunee S; Wongchana W; Palaga T
Anticancer Drugs; 2008 Jun; 19(5):477-86. PubMed ID: 18418214
[TBL] [Abstract][Full Text] [Related]
5. Notch pathway inhibition controls myeloma bone disease in the murine MOPC315.BM model.
Schwarzer R; Nickel N; Godau J; Willie BM; Duda GN; Schwarzer R; Cirovic B; Leutz A; Manz R; Bogen B; Dörken B; Jundt F
Blood Cancer J; 2014 Jun; 4(6):e217. PubMed ID: 24927406
[TBL] [Abstract][Full Text] [Related]
6. [Inhibitory effect of pumpkin protein on expression of Notch signal in RPMI8226 myeloma cells].
Liu TB; Yang P; Xie JM; Hu JD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1012-5. PubMed ID: 25130819
[TBL] [Abstract][Full Text] [Related]
7. Notch signaling deregulation in multiple myeloma: A rational molecular target.
Colombo M; Galletti S; Garavelli S; Platonova N; Paoli A; Basile A; Taiana E; Neri A; Chiaramonte R
Oncotarget; 2015 Sep; 6(29):26826-40. PubMed ID: 26308486
[TBL] [Abstract][Full Text] [Related]
8. Multiple myeloma cells modify VEGF/IL-6 levels and osteogenic potential of bone marrow stromal cells via Notch/miR-223.
Berenstein R; Nogai A; Waechter M; Blau O; Kuehnel A; Schmidt-Hieber M; Kunitz A; Pezzutto A; Dörken B; Blau IW
Mol Carcinog; 2016 Dec; 55(12):1927-1939. PubMed ID: 27023728
[TBL] [Abstract][Full Text] [Related]
9. Notch and BCR signaling synergistically promote the proliferation of Raji B-lymphoma cells.
He F; Wang L; Hu XB; Yin DD; Zhang P; Li GH; Wang YC; Huang SY; Liang YM; Han H
Leuk Res; 2009 Jun; 33(6):798-802. PubMed ID: 18937977
[TBL] [Abstract][Full Text] [Related]
10. PI3K/mTOR inhibition upregulates NOTCH-MYC signalling leading to an impaired cytotoxic response.
Shepherd C; Banerjee L; Cheung CW; Mansour MR; Jenkinson S; Gale RE; Khwaja A
Leukemia; 2013 Mar; 27(3):650-60. PubMed ID: 23038273
[TBL] [Abstract][Full Text] [Related]
11. [Proteasome inhibitor induces apoptosis and influences the expression of Notch1 and NF-kappaB in multiple myeloma RPMI8226 cells].
Wang H; Liu X; Xu B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):531-7. PubMed ID: 18549623
[TBL] [Abstract][Full Text] [Related]
12. Canonical nuclear factor kappaB pathway inhibition blocks myeloma cell growth and induces apoptosis in strong synergy with TRAIL.
Romagnoli M; Desplanques G; Maïga S; Legouill S; Dreano M; Bataille R; Barillé-Nion S
Clin Cancer Res; 2007 Oct; 13(20):6010-8. PubMed ID: 17947462
[TBL] [Abstract][Full Text] [Related]
13. Notch-ing from T-cell to B-cell lymphoid malignancies.
Mirandola L; Comi P; Cobos E; Kast WM; Chiriva-Internati M; Chiaramonte R
Cancer Lett; 2011 Sep; 308(1):1-13. PubMed ID: 21652011
[TBL] [Abstract][Full Text] [Related]
14. Dll1/Notch activation contributes to bortezomib resistance by upregulating CYP1A1 in multiple myeloma.
Xu D; Hu J; De Bruyne E; Menu E; Schots R; Vanderkerken K; Van Valckenborgh E
Biochem Biophys Res Commun; 2012 Nov; 428(4):518-24. PubMed ID: 23111325
[TBL] [Abstract][Full Text] [Related]
15. Importin β1 mediates nuclear factor-κB signal transduction into the nuclei of myeloma cells and affects their proliferation and apoptosis.
Yan W; Li R; He J; Du J; Hou J
Cell Signal; 2015 Apr; 27(4):851-9. PubMed ID: 25643631
[TBL] [Abstract][Full Text] [Related]
16. Targeting Notch Inhibitors to the Myeloma Bone Marrow Niche Decreases Tumor Growth and Bone Destruction without Gut Toxicity.
Sabol HM; Ferrari AJ; Adhikari M; Amorim T; McAndrews K; Anderson J; Vigolo M; Lehal R; Cregor M; Khan S; Cuevas PL; Helms JA; Kurihara N; Srinivasan V; Ebetino FH; Boeckman RK; Roodman GD; Bellido T; Delgado-Calle J
Cancer Res; 2021 Oct; 81(19):5102-5114. PubMed ID: 34348968
[TBL] [Abstract][Full Text] [Related]
17. Evidence that gamma-secretase-mediated Notch signaling induces neuronal cell death via the nuclear factor-kappaB-Bcl-2-interacting mediator of cell death pathway in ischemic stroke.
Arumugam TV; Cheng YL; Choi Y; Choi YH; Yang S; Yun YK; Park JS; Yang DK; Thundyil J; Gelderblom M; Karamyan VT; Tang SC; Chan SL; Magnus T; Sobey CG; Jo DG
Mol Pharmacol; 2011 Jul; 80(1):23-31. PubMed ID: 21450930
[TBL] [Abstract][Full Text] [Related]
18. [Molecular mechanism of Doxorubicin resistance in multiple myeloma cell line].
Lu YY; Xiao CR; Chen HY; Huang X; Hu JS; Lu QY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1336-40. PubMed ID: 25338584
[TBL] [Abstract][Full Text] [Related]
19. Anti-myeloma effect of pharmacological inhibition of Notch/gamma-secretase with RO4929097 is mediated by modulation of tumor microenvironment.
Pisklakova A; Grigson E; Ozerova M; Chen F; Sullivan DM; Nefedova Y
Cancer Biol Ther; 2016 May; 17(5):477-85. PubMed ID: 26934342
[TBL] [Abstract][Full Text] [Related]
20. [Notch signal pathway and chronic lymphocytic leukemia].
Zhang JY; Xu ZS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1472-5. PubMed ID: 25338610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
